ZIVO Bioscience, Inc. (ZIVO)
ZIVO Stock Price Chart
Explore ZIVO Bioscience, Inc. interactive price chart. Choose custom timeframes to analyze ZIVO price movements and trends.
ZIVO Company Profile
Discover essential business fundamentals and corporate details for ZIVO Bioscience, Inc. (ZIVO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
15 Dec 2003
Employees
7.00
Website
https://www.zivobioscience.comCEO
John Bernard Payne
Description
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.
ZIVO Financial Timeline
Browse a chronological timeline of ZIVO Bioscience, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 16 Mar 2026
Upcoming earnings on 12 Nov 2025
Earnings released on 14 Aug 2025
EPS came in at -$0.43 falling short of the estimated -$0.41 by -4.88%.
Earnings released on 15 May 2025
EPS came in at -$1.12 falling short of the estimated -$0.52 by -115.38%.
Earnings released on 18 Mar 2025
EPS came in at -$0.36 surpassing the estimated -$0.56 by +35.71%, while revenue for the quarter reached $90.00K , missing expectations by -50.55%.
Earnings released on 14 Nov 2024
EPS came in at -$0.67 falling short of the estimated -$0.39 by -71.79%, while revenue for the quarter reached $31.50K , missing expectations by -58.00%.
Earnings released on 14 Aug 2024
EPS came in at -$2.78 falling short of the estimated -$0.42 by -561.90%.
Earnings released on 13 May 2024
EPS came in at -$0.47 surpassing the estimated -$0.80 by +41.25%, while revenue for the quarter reached $35.72K , beating expectations by +197.67%.
Earnings released on 15 Mar 2024
EPS came in at -$0.96 , while revenue for the quarter reached $11.80K , missing expectations by -1.67%.
Earnings released on 13 Nov 2023
EPS came in at -$1.05 , while revenue for the quarter reached $11.80K , missing expectations by -1.67%.
Stock split effective on 27 Oct 2023
Shares were split 1 : 6 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Aug 2023
EPS came in at -$1.32 falling short of the estimated -$0.20 by -560.00%, while revenue for the quarter reached $4.05K .
Earnings released on 10 May 2023
EPS came in at -$1.26 falling short of the estimated -$0.24 by -425.00%.
Earnings released on 14 Mar 2023
EPS came in at -$1.68 falling short of the estimated $0.21 by -900.00%.
Earnings released on 14 Nov 2022
EPS came in at -$1.26 falling short of the estimated -$0.23 by -447.83%.
Earnings released on 4 Aug 2022
EPS came in at -$1.32 falling short of the estimated -$0.21 by -528.57%.
Earnings released on 13 May 2022
EPS came in at -$1.32 .
Earnings released on 22 Apr 2022
EPS came in at -$2.04 .
Earnings released on 15 Nov 2021
EPS came in at -$1.26 .
Earnings released on 16 Aug 2021
EPS came in at -$1.68 .
Stock split effective on 28 May 2021
Shares were split 1 : 80 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 17 May 2021
EPS came in at -$4.80 .
Earnings released on 25 Feb 2021
EPS came in at -$2.21 , while revenue for the quarter reached $19.98M .
Earnings released on 12 Nov 2020
EPS came in at -$4.80 .
ZIVO Stock Performance
Access detailed ZIVO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.